{
  "trial_id": "NCT01721577",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Be informed of the nature of the study and have provided written informed consent",
      "label": "met"
    },
    {
      "criterion": "At least 18 years of age",
      "label": "met"
    },
    {
      "criterion": "ECOG performance of 0, 1, or 2, or KPS (Karnofsky performance status) \u2265 60.",
      "label": "met"
    },
    {
      "criterion": "Pathological verification of a WHO grade 4 astrocytoma (glioblastoma or gliosarcoma),",
      "label": "met"
    },
    {
      "criterion": "Expected survival of at least 3 months",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Hepatitis B or Hepatitis C, or HIV infection requiring anti-retroviral therapy",
      "label": "triggers"
    },
    {
      "criterion": "Active malignancy other than basal cell skin cancer",
      "label": "triggers"
    },
    {
      "criterion": "Other active malignancy during the previous 3 years",
      "label": "triggers"
    }
  ],
  "notes": "Patient has a history of anaplastic astrocytoma and is currently undergoing treatment. However, they have hepatitis B and are on anti-retroviral therapy, which makes them ineligible for this trial.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT01721577",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}